TY - JOUR AU - Gerald Illerhaus, AU - Fabian Müller, AU - Friedrich Feuerhake, AU - Arnd-Oliver Schäfer, AU - Christoph Ostertag, AU - Jürgen Finke, PY - 2007/12/31 Y2 - 2024/03/29 TI - High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system JF - Haematologica JA - haematol VL - 93 IS - 1 SE - Letters to the Editor DO - 10.3324/haematol.11771 UR - https://haematologica.org/article/view/4704 SP - 147-148 AB - Thirteen patients (age 38–67 years) with primary lymphoma of the central nervous system (CNS) were treated with methotrexate and cytarabine/thiotepa induction-chemotherapy followed by high-dose carmustine/thiotepa and autologous stem-cell transplantation. Radiotherapy was restricted to patients who did not respond completely to chemotherapy. With a median follow up of 25 months, 3-year DFS and OS was 77%. ER -